See You Next Year! September 22-25, 2025 in Boston

Missed Discovery On Target This Year?

Missed this year's event? Access content across all of this year's programs On-Demand. At your convenience, access archived presentations for On-Demand learning from anywhere, at any time.

2024 Wrap Up

What did you learn most at the 22nd Annual Discovery on Target this past September 30-October 3, 2024? Who did you most value meeting of the over 1,000 international attendees?

The drug discovery science across 220+ presentations included fresh coverage of covalent chemistries and induced proximity, synthetic biology, cancer antibodies, generative AI, and translational models, as well as favorites like kinases, immunomodulation, degraders, membrane proteins, GPCRs, and more.

View More

2024 Testimonials

“It was my first time at Discovery on Target and I really enjoyed conference. The meeting was very high value for us and our work was met with great interest and enthusiasm.”

PhD, Associate Principal Scientist & Program Lead, Dewpoint Therapeutics

“Many thanks for the opportunity to present at and join the DOT conference. I really enjoyed the panel discussion, talks and breakout sessions. Kudos to organizing an excellent conference!”

PhD, Associate Director, Hematology, Novartis Institutes for BioMedical Research

“I want to thank you for inviting me to present at the conference. It was a great conference; I have learned a lot from the other speakers and enjoyed the experience very much.”

PhD, Senior Vice President, Head of Research & Preclinical, Chief CMC Officer, Graviton Bioscience

View All Testimonials

SEARCH AGENDA

September 30

Strategies for Targeting Kinases

Covalent Chemistries and Induced Proximity NEW

Emerging Immune Modulation Strategies

Synthetic Biology for Drug Discovery and Therapy NEW

October 1-2

Degraders and Molecular Glues – Part 1

Lead Generation Strategies

Small Molecules for Cancer Targets

Antibodies Against Membrane Protein Targets

Small Molecules Targeting RNA

AI/ML-Enabled Drug Discovery – Part 1

Physiologically Relevant Translational Models

GPCR Pharmacodynamics: Kinetics, Allosterism, and Biased Agonism in Pharma Discovery NEW

October 2-3

Degraders and Molecular Glues – Part 2

Target Identification Strategies

GPCR-Based Drug Discovery

Cancer Antibodies

Targeting Transcription Factors

AI/ML-Enabled Drug Discovery – Part 2

Drug Exposure at the Target: The Role of ADME and Pharmacokinetics NEW

View Attendee List

Join Us in Boston for Discovery On Target 2024!

Discovery on Target highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

We aim to meet your research needs. Visit numerous concurrent sessions all week for informative presentations, lively dialogue, and meaningful connections with peers. Customize your experience further through focused short courses, training seminars, interactive breakout discussions, and networking options that help you engage with experts and solutions providers.

Our four-day event brings back popular topics like kinases, immunomodulation, and degraders, plus new coverage of covalent chemistries and induced proximity, synthetic biology, cancer antibodies, generative AI, and translational models.

HOTEL & TRAVEL

POSTERS

SHORT COURSES

2024 Plenary Keynote Program

Discovery of Transformative Rx to Treat Obesity and Related Diseases

Richard DiMarchi, PhD, Distinguished Professor of Chemistry and Chair, Biomolecular Sciences, Indiana University; former Executive, Lilly and Novo Research Labs